- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | CeriBell (NASDAQ:CBLL) Shares Down 2.6% - Should You Sell? | 2 | MarketBeat | ||
| 19.11. | Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing | 5 | GlobeNewswire (USA) | ||
| 13.11. | CeriBell GAAP EPS of -$1.85, revenue of $17.2M | 1 | Seeking Alpha | ||
| 12.11. | Ceribell, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| CERIBELL Aktie jetzt für 0€ handeln | |||||
| 07.11. | Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum | 1 | GlobeNewswire (USA) | ||
| 05.11. | TD Cowen starts coverage on Ceribell stock with Buy, highlights innovative tech | 1 | Investing.com | ||
| 05.11. | Ceribell stock a buy as JPMorgan highlights disruptive tech in $3B seizure market | 3 | Investing.com | ||
| 05.11. | Ceribell-Aktie als Kaufempfehlung: JPMorgan hebt disruptive Technologie im 3-Milliarden-US-Dollar-Markt für Epilepsie hervor | 4 | Investing.com Deutsch | ||
| 15.10. | Ceribell, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.10. | Ceribell CEO Jane Chao explains why now was the time for its upsized IPO | 1 | FierceBiotech | ||
| 15.10. | CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | 104 | PR Newswire | SUNNYVALE, Calif., Oct. 15, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of... ► Artikel lesen | |
| 11.10. | CeriBell, EEG developer, sees stock rally 35% following $180M IPO | 1 | Seeking Alpha | ||
| 11.10. | Ceribell, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 11.10. | Neurotech company CeriBell prices $180.3M IPO | 1 | MassDevice | ||
| 11.10. | Seizure diagnostic company CeriBell prices IPO at $17, the high end of the upwardly revised range | 1 | Renaissance Capital | ||
| 11.10. | CeriBell Prices Upsized 10.61M Share IPO at $17/sh | 1 | Investing.com | ||
| 11.10. | CeriBell prices IPO at $17 per share | 2 | Seeking Alpha | ||
| 11.10. | CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering | 149 | PR Newswire | SUNNYVALE, Calif., Oct. 10, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of... ► Artikel lesen | |
| 09.10. | Seizure diagnostic company CeriBell ups shares by 58%, increases range ahead of $175 million IPO | 2 | Renaissance Capital | ||
| 09.10. | CeriBell, Inc Files for Upsized 10.6M Share IPO at a Higher $16-$17/sh Price Range | 1 | Investing.com |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 51,20 | -1,73 % | Siemens überprüft Healthineers-Beteiligung | DJ Siemens überprüft Healthineers-Beteiligung
DOW JONES--Der Technologiekonzern Siemens stellt seine Mehrheitsbeteiligung an der Medizintechniktochter Siemens Healthineers infrage. "Wir bewerten... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 80,96 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 33,540 | +0,18 % | Fresenius Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| FRESENIUS MEDICAL CARE | 44,160 | -0,27 % | INDEX-MONITOR: Covestro fällt mit Übernahme aus dem Dax - FMC folgt | FRANKFURT/ZUG (dpa-AFX) - Der vor der Übernahme stehende Kunststoffkonzern Covestro fliegt am heutigen Freitag aus dem deutschen Aktienleitindex Dax . Grund für die außerplanmäßige Änderung der Indexzusammensetzung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,520 | -2,36 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| GERRESHEIMER | 71,00 | -0,21 % | Gerresheimer SCHOCKIERT Anleger: Steht die Aktie jetzt vor einem Kursdesaster? | ||
| PROGYNY | 16,930 | 0,00 % | Progyny (NASDAQ:PGNY) Shares Gap Up After Insider Buying Activity | ||
| ADAPTHEALTH | 9,360 | 0,00 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| NANO-X IMAGING | 7,520 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| GENEDX | 76,85 | 0,00 % | How IBD Stock Of The Day GeneDx Landed On The IBD 50 And Notched A 2,500% Gain | ||
| MIMEDX | 9,480 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| RXSIGHT | 33,820 | 0,00 % | Pre-market Movers: Lytus Technologies, Lumen Technologies, RxSight, Jumia Technologies, Helport AI | TOKYO (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.35 A.M. ET).In the Green Lytus Technologies Holdings PTV. Ltd. (LYT) is up over... ► Artikel lesen | |
| UNITEDHEALTH | 486,65 | +0,16 % | Unitedhealth Aktie: Neue Projektfortschritte! | Die UnitedHealth Group zeigt sich zum Jahresende 2024 mit gemischten Signalen. Der aktuelle Aktienkurs liegt bei 509,98 USD und verzeichnet einen leichten Rückgang von 0,26% zum Vortag. Besonders bemerkenswert... ► Artikel lesen | |
| EUROPEAN WAX CENTER | 6,370 | +2,08 % | European Wax Center, Inc. Reports Third Quarter Fiscal Year 2024 Results | Reiterates fiscal 2024 financial outlook Updates fiscal 2024 outlook for net new centers Third Quarter Fiscal 2024 versus 2023 Net new centers increased 3.7% to 1,064 total centers in 45 statesSystem-wide... ► Artikel lesen | |
| ECKERT & ZIEGLER | 44,500 | +0,23 % | Eckert&Ziegler SCHOCKIERT Anleger: Steht die Aktie jetzt vor einem Kursdesaster? |
CERIBELL INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 25,860 Euro und damit -2,23 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CERIBELL INC finden Sie auf Wallstreet Online.
